Clinical Trials Browser

Carcinoma, Hepatocellular × Erlotinib Hydrochloride × 1 year × Clear all

NCT04172779 2026-05-01

ECHO-B

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis